Accelerated Epigenetic Aging and Prospective Morbidity and Mortality Among U.S. Veterans
- PMID: 40259495
- PMCID: PMC12199239
- DOI: 10.1093/gerona/glaf088
Accelerated Epigenetic Aging and Prospective Morbidity and Mortality Among U.S. Veterans
Abstract
Background: Epigenetic aging measures have promise as surrogate health outcomes in randomized control trials and observational cohort studies. The value of these measures, however, will reflect the extent to which they are associated with prospective health outcomes in real-world medical settings.
Methods: Using data from 2 216 post-9/11 veterans from the VISN 6 MIRECC's Post-Deployment Mental Health Study, we examined whether accelerated epigenetic aging, assessed by DunedinPACE, was associated with prospective chronic disease morbidity, predicted healthcare costs, and mortality over an average of 13.1 years of electronic health record follow-up.
Results: Veterans with faster DunedinPACE aging scores developed more chronic disease over the subsequent 5 years (RR, 1.25; 95% CI, 1.14-1.36), 10 years (RR, 1.31; 95% CI, 1.21-1.40), and 15 years (RR, 1.36; 95% CI, 1.22-1.52). Faster aging scores were also associated with increases in predicted healthcare costs over the next 5 years (β = 0.08; 95% CI, 0.03-0.13), 10 years (β = 0.23, 95% CI, 0.15-0.31), and 15 years (β = 0.21; 95% CI, 0.11-0.30). Faster DunedinPACE aging scores were associated with greater risk for incident myocardial infarction (84%), stroke (38%), diabetes (56%), cancer (25%), liver disease (44%), and renal disease (34%), as well as greater risk of mortality due to all-causes (38%) and chronic disease (74%). These results remained when adjusting for demographic, biomarker, and smoking covariates.
Conclusions: Our findings suggest DunedinPACE is a biomarker of accelerated aging that is prospectively associated with chronic disease morbidity and mortality, as assessed using health records from an integrated healthcare system.
Keywords: Biological aging; Chronic disease; DNA methylation; Mortality; Veterans.
Published by Oxford University Press on behalf of the Gerontological Society of America 2025.
Conflict of interest statement
Drs. Terrie Moffitt, Avshalom Caspi, and Karen Sugden are named as an inventor on a license issued by Duke University for the DunedinPACE. The algorithm to calculate DunedinPACE is publicly available on Github,
Update of
-
Accelerated epigenetic aging and prospective morbidity and mortality among U.S. veterans.medRxiv [Preprint]. 2024 Oct 23:2024.10.23.24315691. doi: 10.1101/2024.10.23.24315691. medRxiv. 2024. Update in: J Gerontol A Biol Sci Med Sci. 2025 Jun 10;80(7):glaf088. doi: 10.1093/gerona/glaf088. PMID: 39502668 Free PMC article. Updated. Preprint.
References
-
- Rutledge J, Oh H, Wyss-Coray T.. Measuring biological age using omics data. Nat Rev Genet. 2022;23(12):715–727. https://doi.org/ 10.1038/s41576-022-00511-7 - DOI - PMC - PubMed
-
- Moqri M, Herzog C, Poganik JR, et al. ; Biomarkers of Aging Consortium. Biomarkers of aging for the identification and evaluation of longevity interventions. Cell. 2023;186(18):3758–3775. https://doi.org/ 10.1016/j.cell.2023.08.003 - DOI - PMC - PubMed
-
- Belsky DW, Caspi A, Corcoran DL, et al. DunedinPACE, a DNA methylation biomarker of the pace of aging. Elife. 2022;11:e73420. https://doi.org/ 10.7554/eLife.73420 - DOI - PMC - PubMed
-
- Lu AT, Quach A, Wilson JG, et al. DNA methylation GrimAge strongly predicts lifespan and healthspan. Aging (Albany NY). 2019;11(2):303–327. https://doi.org/ 10.18632/aging.101684 - DOI - PMC - PubMed
-
- Horvath S. DNA methylation age of human tissues and cell types [published correction appears in Genome Biol. 2015;16:96. doi: 10.1186/s13059-015-0649-6]. Genome Biol. 2013;14(10):R115. https://doi.org/ 10.1186/gb-2013-14-10-r115 - DOI - PMC - PubMed
MeSH terms
Grants and funding
- R01 AG073207/AG/NIA NIH HHS/United States
- (#IK6BX006523/Rehabilitation Research and Development
- #I01RX003120/Clinical Science Research and Development
- IK6 CX002767/CX/CSRD VA/United States
- #IK2CX000525/Rehabilitation Research and Development
- #I01BX002577/Biomedical Laboratory Research and Development
- IK2 CX002694/CX/CSRD VA/United States
- IK2 CX000525/CX/CSRD VA/United States
- IK6 BX006523/BX/BLRD VA/United States
- IK6 BX003777/BX/BLRD VA/United States
- I01 RX003120/RX/RRD VA/United States
- I01 BX002577/BX/BLRD VA/United States
- #lK6BX003777/Biomedical Laboratory Research and Development
- #R01AG073207/Biomedical Laboratory Research and Development
LinkOut - more resources
Full Text Sources
Medical